XML 22 R9.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net loss $ (3,407) $ (2,300)
Reconciliations of net loss to net cash provided by operating activities:    
Depreciation and amortization 1,000 969
Non-cash lease expense 1,724 1,773
Investment (accretion) amortization and (gains) losses recognized 81 (130)
Deferred Income taxes 508  
Share-based compensation 342 1,387
Changes in certain operating assets and liabilities:    
Trade accounts receivable (2,229) (2,560)
Income taxes (1,102) (843)
Prepaid expenses and other (1,592) (2,752)
Accounts payable (1,660) 1,021
Accrued payroll, payroll taxes and related benefits 6,406 30,647
Other accrued liabilities (2,095) (3,512)
Workers' compensation claims liabilities 6,452 9,508
Safety incentives liability (1,620) (2,282)
Operating lease liabilities (1,672) (1,374)
Other assets and liabilities, net (95) 1,220
Net cash provided by operating activities 1,041 30,772
Cash flows from investing activities:    
Purchase of property, equipment and software (3,439) (1,798)
Purchase of investments (23,722) (8)
Proceeds from sales and maturities of investments 21,758 15
Purchase of restricted investments (1,828) (2,023)
Proceeds from sales and maturities of restricted investments 14,449 30,859
Net cash provided by investing activities 7,218 27,045
Cash flows from financing activities:    
Payments on long-term debt (55) (55)
Repurchase of common stock (2,987)  
Common stock repurchased on vesting of stock awards (378) (178)
Dividends paid (2,262) (1,852)
Proceeds from exercise of stock options 904 122
Net cash used in financing activities (4,778) (1,963)
Net increase in cash, cash equivalents and restricted cash 3,481 55,854
Cash, cash equivalents and restricted cash, beginning of period 273,341 140,702
Cash, cash equivalents and restricted cash, end of period $ 276,822 $ 196,556